| 93. | ||
|
Maertens J, Raad I, Sable C, et al. Multicenter, comparative study to evaluate safety and efficacy of caspofungin in adults with invasive aspergillosis refractory or intolerant to amphotericin B, AMB lipid formulations, or azoles [Abstract 1103]. Presented at 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, 2000.
|
||
| Close this window | ||